Drug intelligence / Profile preview

MYCB1-BDC

Development stage: Unknown
Lead developer: MYCB1
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral, Sublingual

Overview

MYCB1-BDC is a standardized, pharmaceutical-grade medical cannabis extract developed and marketed by MYCB1. It is formulated as an oily oral solution containing tetrahydrocannabinol (THC) and cannabidiol (CBD) in specific ratios, such as 25:1 and 50:1. The extract is primarily prescribed in Germany for the management of chronic pain, spasticity associated with multiple sclerosis, and other conditions responsive to cannabinoid therapy. THC acts as a partial agonist at cannabinoid CB1 and CB2 receptors, while CBD modulates these receptors and other targets to provide analgesic, anti-inflammatory, and muscle-relaxant effects.

Brand names: MYCB1-BDCMYCB-1-BDCMYCB 1-BDC
Other names: MYCB1 BDCMYCB-1 BDCMYCB 1 BDCMYCB1-BDC 25:1MYCB1-BDC 50:1Ölige Cannabisharzöl-Lösung MYCB1 BDC 25:1Ölige Cannabisharzöl-Lösung MYCB1 BDC 50:1

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on MYCB1-BDC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYCB1-BDC.

Explore the full profile